{
    "title": "Drugmakers look to push the boundaries of old age",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2822782/Drugmakers-look-push-boundaries-old-age.html",
    "date": "2014-11-06",
    "keywords": [
        "drug",
        "age",
        "system",
        "interest",
        "research",
        "company",
        "process",
        "novartis",
        "treatment",
        "field",
        "journal",
        "lifespan",
        "medicine",
        "trial",
        "immunosenescence",
        "immune",
        "mice",
        "everolimus",
        "benefit",
        "study",
        "insulin",
        "university",
        "gmt",
        "november",
        "email",
        "caroline",
        "copleyzurich",
        "ambition",
        "lifescience",
        "calico",
        "google",
        "year",
        "diseasesaway",
        "limelight",
        "beyondeverybody",
        "population",
        "thomsen",
        "chief",
        "science",
        "officer",
        "time",
        "history",
        "paper",
        "thursdaybut",
        "burden",
        "diseaseat",
        "world",
        "health",
        "organization",
        "number",
        "dementia",
        "goal",
        "elixir",
        "life",
        "pill",
        "period",
        "sickness",
        "zhavoronkov",
        "executive",
        "biotech",
        "prevention",
        "person",
        "healthcare",
        "sense",
        "onset",
        "boosterresearch",
        "attention",
        "pharma",
        "effectmoreover",
        "europe",
        "something",
        "diseasedespite",
        "pilot",
        "cancer",
        "deterioration",
        "cause",
        "disease",
        "rapamycin",
        "effect",
        "humansthe",
        "ageing",
        "decadeslong",
        "trialsfor",
        "target",
        "head",
        "mark",
        "fishmanthe",
        "companys",
        "workaround",
        "course",
        "flu",
        "vaccine",
        "response",
        "percent",
        "door",
        "efficacy",
        "fishman",
        "work",
        "way",
        "market"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}